NGNE vs TECH · rev $925.0K vs P/E 65, rev $1.22B
Neurogene Inc (NGNE) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Neurogene Inc (NGNE) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported NGNE revenue for 2024-12-31 was $925.0K. Net income was -$75.1M. NGNE currently screens at market cap $286.5M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
NGNE currently screens at market cap $286.5M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the NGNE and TECH stock pages for the full models.
Not investment advice.